ResearcherBaylor College of MedicineNo recent work listed
Rafael A. Cubas
Matched on ORCID iD 0000-0002-3450-9054; OpenAlex author ID A5076232585. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2011: 1 paper · 2012: none · 2013: 1 paper
Papers 2
- Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS-… Co-author DOI 10.1371/journal.pone.0068303↗
- Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. Co-author DOI 10.1097/cji.0b013e318209ee72↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qizhi Cathy Yao · 2 shared papers, 2011–2013 · strength 0.08
- Paper Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reducti… DOI 10.1371/journal.pone.0068303↗
- Paper Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. DOI 10.1097/cji.0b013e318209ee72↗
- Sheng Zhang · 2 shared papers, 2011–2013 · strength 0.08
- Paper Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reducti… DOI 10.1371/journal.pone.0068303↗
- Paper Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. DOI 10.1097/cji.0b013e318209ee72↗
- Changyi Chen · 2 shared papers, 2011–2013 · strength 0.08
- Paper Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reducti… DOI 10.1371/journal.pone.0068303↗
- Paper Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. DOI 10.1097/cji.0b013e318209ee72↗
- Lin-Kin Yong · 1 shared paper, 2013 · strength 0.04
- Min Li · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.